GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes: Selection of NN2211 for clinical development
- 1 January 2001
- journal article
- Published by Portico in Drugs of the Future
- Vol. 26 (7), 0677
- https://doi.org/10.1358/dof.2001.026.07.628723